Airija - anglų - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - lansoprazole - capsules gastro-resistant - 15 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

arrow aps - repaglinide - tablets - 0.5 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

arrow aps - repaglinide - tablets - 1 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

arrow aps - repaglinide - tablets - 2 milligram

Pietų Afrika - anglų - South African Health Products Regulatory Authority (SAHPRA)

bayer -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - repaglinide -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - dabrafenib mesilate -

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

biomed limited - methadone hydrochloride 2 mg/ml;   - oral solution - 2 mg/ml - active: methadone hydrochloride 2 mg/ml   excipient: purified water sunset yellow fcf - oral methadone is used in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

biomed limited - methadone hydrochloride 10 mg/ml;   - oral solution - 10 mg/ml - active: methadone hydrochloride 10 mg/ml   excipient: amaranth purified water - oral methadone is used in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

biomed limited - methadone hydrochloride 5 mg/ml;   - oral solution - 5 mg/ml - active: methadone hydrochloride 5 mg/ml   excipient: purified water - oral methadone is used in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.